Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Related Articles


How to Implant His Bundle and Left Bundle Pacing Leads: Tips and Pearls

Shunmuga Sundaram Ponnusamy, Pugazhendhi Vijayaraman,


Citation: Cardiac Failure Review 2021;7:e13.

The Future of Telemedicine in the Management of Heart Failure Patients

José Silva-Cardoso, José Ramón González Juanatey, Josep Comin-Colet,


Citation: Cardiac Failure Review 2021;7:e11.

Hyperkalaemia in Heart Failure

Umar Ismail, Kiran Sidhu, Shelley Zieroth,


Citation: Cardiac Failure Review 2021;7:e10.

Enterovirus-related Myocarditis in a Rituximab-treated Patient

Ava Diarra, Guillaume Gantois, Mouna Lazrek,


Citation: Cardiac Failure Review 2021;7:e09.